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ABSTRACT There are current limitations in the recording technologies for measuring EEG activity in
clinical and experimental applications. Acquisition systems involving wet electrodes are time-consuming
and uncomfortable for the user. Furthermore, dehydration of the gel affects the quality of the acquired data
and reliability of long-term monitoring. As a result, dry electrodes may be used to facilitate the transition
from neuroscience research or clinical practice to real-life applications. EEG signals can be easily obtained
using dry electrodes on the forehead, which provides extensive information concerning various cognitive
dysfunctions and disorders. This paper presents the usefulness of the forehead EEG with advanced sensing
technology and signal processing algorithms to support people with healthcare needs, such as monitoring
sleep, predicting headaches, and treating depression. The proposed system for evaluating sleep quality is
capable of identifying five sleep stages to track nightly sleep patterns. Additionally, people with episodic
migraines can be notified of an imminent migraine headache hours in advance through monitoring forehead
EEG dynamics. The depression treatment screening system can predict the efficacy of rapid antidepressant
agents. It is evident that frontal EEG activity is critically involved in sleepmanagement, headache prevention,
and depression treatment. The use of dry electrodes on the forehead allows for easy and rapid monitoring
on an everyday basis. The advances in EEG recording and analysis ensure a promising future in support of
personal healthcare solutions.
INDEX TERMS Depression, forehead EEG, healthcare, migraine, sleep.
I. INTRODUCTION
The electroencephalogram (EEG) is a commonly used med-
ical testing device that detects abnormal electrical activity in
the brain. Significant advances in neuroscience, sensor tech-
nologies [1], [2], and efficient signal processing algorithms
have facilitated the transition from clinical-oriented diag-
noses and research to personal healthcare applications. It is
evident through the literature that there is promising future for
the everyday use of EEG for monitoring and tracking health.
Conventional wet adhesive Ag/AgCl electrodes that are
placed on a cap and connected to a signal amplifier are
the most common devices for recording EEG signals from
the scalp in a clinical context. To ensure that a high-quality
EEG signal is obtained, a time-consuming process requiring
proper skin preparation and electrolyte application must be
performed. Recent advances in material technology have led
to progress in the development of dry EEG sensors avoiding
a conductive gel. Furthermore, miniature circuits—integrated
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with signal amplifiers, a wireless transmission component,
and long-life battery—transform a restrictive acquisition sys-
tem into a portable device. However, it is challenging to
maintain good contact between the electrodes and a hairy
scalp. Despite a signal quality assessment model [3], invalid
EEG data collection is inevitable—limiting the practicability
of EEG in healthcare.
The forehead is an ideal location on the scalp for attach-
ing EEG electrodes as it is not covered in hair. Preparing
the forehead for EEG placement takes only a few minutes,
which is a significant time reduction [4]. Non-hairy regions
of the forehead can be used to extract rich information that
originates in the anterior cingulate cortex, prefrontal cortex
and the frontoparietal cortical network, which are associ-
ated with many cognitive abilities and dysfunctions. Given
this unique feature, most existing consumer brain-computer
interfaces (BCI) and clinical applications rely on forehead
electrodes [5], [6].
One of the most successful consumer products is the sleep
tracking device, which is widely advertised to provide posi-
tive effects on overall health [7]. Sleep is suggested to play
an important role in restitution [8]. Numerous pathologies
are related to sleep; therefore, a method for evaluating sleep
quality is desirable. Many wristbands evaluate the quan-
tity and quality of sleep using an actigraph with a built-
in 3D accelerometer [7], [9]. However, wristband devices
do not differentiate the distinct phases of sleep (light sleep,
deep sleep, and rapid eye movement sleep), which is impor-
tant for physicians to evaluate sleep patterns. Polysomnog-
raphy (PSG) [10] is the standard process to record and
comprehend the biophysiological changes that occur during
sleep; PSG is performed during clinical sleep tests. Among
PSG methods, the EEG yields the most important infor-
mation about sleep oscillations, such as K-complex, spin-
dle, and delta waves that are generated in various sleep
stages [11]. Regarding the brain region, sleep is characterized
by a fronto-occipital EEG power gradient, of which frontal
areas are specifically involved in sleep homeostasis [12], [13].
A lack of adequate sleep has deleterious effects—particularly
on alertness, attention, decision-making, and cognitive
processes, which are associated with the frontal lobe
function [14]. The theta power during prolonged wakefulness
has a particular frontal concentration, suggesting that frontal
regions may provide a marker for sleep propensity during
wakefulness. Additionally, previous EEG findings concern-
ing insomnia—a sleep disorder of inadequate nighttime sleep
with difficulty in initiating and maintaining sleep [15]—have
revealed increased signals with high frequencies in patients
with primary insomnia.
Prevention is key to reducing healthcare costs; a suc-
cessful case is migraine prevention. A migraine is charac-
terized by recurrent headaches and is particularly prevalent
in developed countries [16]. When a headache occurs, it if
difficult for patients to maintain concentration and perform
daily activities; this impairment results in considerable eco-
nomic losses. Lack of sleep and excessive sleep are both
deemed triggers for migraines [17]. The EEG patterns that
are observed inmigraine patients support a physiological con-
nection between sleep and migraines [18]. Most EEG studies
of migraines describe functional changes between, before
and during attacks, including abnormal effective connec-
tivity, hyperresponsivity to repeated sensory stimuli with
abnormal temporal processing, the malfunctioning sequen-
tial recruitment of neuronal networks, and impaired habitua-
tion [19], [20]. EEG patterns reflect the dynamic complexity
of patients’ brains [21], which may facilitate the prediction of
imminent migraine headaches hours in advance and monitor
the effects of therapeutic interventions. Predicting the onset
of a migraine is important, as the use of preventive medica-
tions before an attack can significantly reduce the severity
and duration of a headache. Therefore, it is important to
investigate the fundamental patterns from EEG activity to
distinguish the inter-ictal phase from the pre-ictal phase.
Personalized medicine is developing rapidly [22].
Recently, the biomarker used to optimize the initial
treatment selection in depression has been extensively
explored [22]–[24]. Depression is a disorder of the affective
system, with a lifetime prevalence of approximately 13%
in men and 21% in women [25]. The major symptoms of
depression include low or depressed mood, anhedonia, and
low energy or fatigue. Overall, one-third of patients with a
major depressive disorder do not respond to existing antide-
pressants; researchers are eager to explore a biomarker that
can predict the efficacy of a treatment before antidepressants
are given and an appropriate treatment is prescribed. Pre-
vious studies have demonstrated the broad use of EEG in
clinics to study antidepressant treatment responses [26], [27].
Furthermore, studies have shown that discriminative
EEG patterns may help patients predict the effects of
antidepressants as treatment [27]. Theta (4-7.5 Hz) and
alpha (8-12 Hz) activity-derived measures indicated that the
response effects of antidepressants correlated to dynamic
changes of EEG power in the forehead area [27]–[30]. Thus,
the forehead EEG may have important implications for the
diagnosis and treatment of depression. EEG signals can be
used to guide the development of personalized medicine,
including the selection of an appropriate dose, and optimal
therapies.
This paper presents practical methods for monitoring sleep
quality, warning for oncoming of migraine attacks, and
screening depression treatments. The proposed solutions are
based on EEG patterns extracted from the forehead area using
a wireless and dry EEG system [1], [2], [31]. The basic
principles of each method are introduced, and the feasibility
of their use in real-life applications is demonstrated.
II. WEARABLE HEADBAND WITH DRY ELECTRODES FOR
FOREHEAD EEG SENSING
Wet electrodes are commonly used to measure EEG sig-
nals; proper skin preparation and the application of a
conductive gel yields strong EEG signals. However,
these processes are typically troublesome for users. The
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FIGURE 1. Wearable headband with dry electrodes for forehead EEG sensing. (A) Silicon-based EEG sensor. Length, width, and height of the electrode are
18, 15, and 2 mm, respectively, in each dimension. (B) Channel placement. Five electrodes are embedded. (C) EEG acquisition circuit. Major components
include amplifiers, analog-to-digital converter units, a microcontroller unit, and a wireless module. The size of the proposed circuit boards is
30×25×5 mm3. (D) Wearable headband. Users can easily adjust to fit as tight or loose as desired. One reference electrode is used in contact with a user’s
earlobe. (E) Forehead EEG sensing. The developed EEG system is designed to easily wear and provide access to the forehead locations without gels or
other preparation.
development of wireless and wearable EEG systems,
such as Cognionics [32], Enobio [33], NeuroSky [34],
DSI 10/20 [35], and imec [36], have been developed to miti-
gate the application process. Researchers have also developed
distinct novel dry-contact EEG sensors, including spring-
loaded [37] and foam-based sensors [37], which can effi-
ciently reduce the required preparatory work without the
use of a conductive gel. The spring-loaded sensor [37] was
proposed for use on hairy sites without skin preparation or
the use of a conductive gel. Each sensor was designed with
a probe head, plunger, spring, and barrel. The probes were
inserted into a flexible substrate using a one-time forming
process based on an established injection molding procedure.
With spring contact probes, the flexible substrate allows
for high geometrical conformity between the sensor and
the irregular scalp surface and generates a low skin-sensor
interface impedance. Additionally, the flexible substrate has
a sensor buffer effect, which eliminates pain when a force is
applied.
The dry foam electrode [37] is fabricated by covering
an electrically conductive polymer foam with conductive
fabric and can be used to measure bio-potentials at non-
hairy sites, such as the forehead, without skin preparation
or the use of a conducting gel. The foam substrate of a dry
electrode provides high geometric conformity to an irregular
scalp surface to maintain low skin-electrode impedance—
even under motion. The presence of a new sensor made
of a silicon-based conductive material further satisfies the
requirements of being conductive, flexible and non-irritating
to the skin [31].
In laboratory- and clinical-based EEG devices, the mea-
sured brain activity is transmitted via a cable connected from
the EEG cap to a computer. This cable limits the usefulness
of BCI. To solve this problem, the developed EEG headband
(Fig. 1) features a wireless transmissionmodule and a charge-
able battery that support recordings without connection to a
computer and enable users to move freely. With this freedom,
wireless and wearable EEG devices have been used in experi-
ments involving complex activities such as driving [38]. This
convenient EEG acquisition system can be used to improve
our understanding of complex coordinated- and multi-joint
naturalistic behaviors in operating environments.
A. NOVEL FLEXIBLE SILICON-BASED DRY SENSORS
Themajor components of the proposed silicon-based dry sen-
sor (Figs. 1A and 1B) include silicon, silver, AgSiO2, gel and
thick-film pastes. A compound containing the correct ratio
of components provides low impedance and high flexibility.
The proposed sensor has a lightweight design and uses lim-
ited material to optimize its sensitivity. Several molds were
used to produce different sensor shapes for use in different
areas. The fabrication procedure included high-temperature
and high-pressure treatments. The manufacturing conditions
(i.e., temperature, flow and pressure) were controlled in all
bind molding processes. If the electrode was to be combined
with metal contact bars, a special conductive gel was used in
the bind molding process. Temperature control is important
as the materials (i.e., metal, conductive gel, silicon and silver-
based material) have different expansion coefficients. Addi-
tionally, forming different electrodes shapes requires a highly
precise process. The flexible silicon-based dry sensor design
can improve the signal quality and extend the life-cycle of
electrodes.
B. LIGHTWEIGHT HEADBAND THAT INCORPORATES
MINIATURE DATA ACQUISITION CIRCUITRY AND
WIRELESS TELEMETRY
As presented in Fig. 1C, two circuit boards are embedded
in the acquisition system; the major components include
amplifiers, analog-to-digital converter (ADC) units, a micro-
controller unit, and a wireless module (Bluetooth unit). The
size of the proposed circuit boards is 30×25×5 mm3. The
circuit boards and battery are small enough to be housed
in the EEG device (Fig. 1D). In the EEG measurement
process, analog EEG signals were measured using dry sen-
sors and preamplified using instrumentation amplifiers. The
preamplifier provides a high input impedance and high
common-mode rejection ratio (CMRR) and amplifies the
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microvolt-level EEG signals into the detectable range. Then,
the analog EEG signal was transformed to a digital signal
using an ADC [39]. A microcontroller was used to pack
the digital data from each channel into Bluetooth packets.
The packets were switched to a Bluetooth module using a
universal asynchronous receiver/transmitter.
The gain of the preamplifier unit was set to 1361 (default),
and the cut-off frequency was regulated at 0.23 Hz using a
high-pass filter. The ADC setting was configured to provide
a 24-bit resolution of EEG signals at a sampling rate of
250/500 Hz. The power-line interference was removed by a
microcontroller using a moving average filter (i.e., notch fil-
ter) with a frequency of 60 Hz. The digitalized and processed
signals were transmitted to the receiving application via a
Bluetooth module with a baud-rate of 921600 bits/s. Power
was supplied by a high-capacity (750 mAh, 3.0 V) Li-ion
battery capable of continuous operation for 8 to 10 hours.
C. SIGNAL PRE-PROCESSING
The EEG data were analyzed with EEGLAB, an open- source
MATLAB toolbox for electrophysiological signal processing
and analysis [40]. To avoid artifact interference in the models,
EEG data were bandpass-filtered from 1 to 30 Hz using a
zero-phase FIR filter before being inspected by experienced
EEG specialists. Then, the EEG signals were inspected again
using the Automatic Channel Rejection (ACR) function in
EEGLAB to remove noisy channels. The processed EEG
signals were used for further analysis. Several methods of
artifact removal have been proposed for single-channel col-
lection of EEG data from everyday tasks [41]. Single-channel
data acquisition is appropriate for use in portable environ-
ments with the constraints of a wearable sensor. Algorithms
based on single-channel independent component analysis,
empirical mode decomposition, or wavelet decomposition
have a low computing cost and address the risk of artifacts.
III. SYSTEM FOR EVALUATING QUALITY OF SLEEP
Sleep monitoring is essential when evaluating individual
health. Sleep quality is evaluated by sleep duration and
continuity [8]. According to Rechtschaffen and Kales [42],
sleep can be divided into wakefulness (W), movement,
rapid eye movement (REM) and sleep stages S1, S2, S3,
and S4. In the guidelines of the American Academy of
Sleep Medicine (AASM) [43], sleep stages S1 to S4 are
referred to as non-REM stage 1 (N1), stage 2 (N2), and
stage 3 (N3). N3 involves slow wave sleep (SWS), which
combines sleep stages S3 and S4 based on the sleep stage
criteria of Rechtschaffen and Kales. The PSG [10], consisting
of at least 11 channels of EEG, electromyography (EMG),
electrooculography (EOG), oxygen saturation (SpO2), and
electrocardiography (ECG) is the most common test in sleep
diagnoses.
Generally, a well-trained sleep technician scores each
30 s EEG data point through visual inspection based on
the AASM. An epoch is scored as W when more than 50%
of the 1 s subepochs are dominated by the alpha (8-12 Hz)
rhythm. An epoch is scored as N1 when the alpha rhythm
is attenuated and replaced by the theta (5-7 Hz) rhythm.
An epoch is scored as N2 when the K-complex or sleep
spindle (12-14 Hz) occurs with a theta background rhythm.
An epoch is scored as N3 when more than 20% of the sube-
pochs exhibit high-amplitude slow wave activity. However,
this visual inspection process is time-consuming and labori-
ous. To address this issue, this work proposes an automatic
sleep stage classification system [44].
A. PARTICIPANTS AND DATA ACQUISITION
Ten healthy adults (males, age 24±6 years) were recruited
for this sleep study. All subjects were required to sleep
for one night in the sleep laboratory at National Chiao
Tung University, Taiwan. All experimental procedures were
approved by the local ethics committee (Institutional Review
Board of Taipei Veterans General Hospital, Taiwan). The
forehead EEG signals (Fp 1 and Fp2) and the PSG signals
were recorded simultaneously at a sampling rate of 256 Hz
(Sandman Elite, Nellcor Puritan Bennett [Melville] Ltd.,
Kanata, Ontario, Canada). Each dataset contained five to
eight hours of forehead EEG signals and a complete PSG
signal. Each 30 s epoch was scored as W, REM, N1, N2,
and N3 by a sleep specialist who has over thirty years of
experience in clinical sleep diagnoses. In total, there were
1518, 1084, 3119, 1283, and 1247 epochs scored as W, N1,
N2, N3, and REM, respectively.
B. AUTOMATIC CLASSIFICATION OF SLEEP STAGES
As presented in Fig. 2, the main components of the proposed
sleep stage classification system include preprocessing, fea-
ture extraction, and classification. In the preprocessing step,
the recorded signals were down-sampled to 128 Hz to reduce
the volume of data and then filtered through a 0.5-50 Hz
band-pass filter to eliminate the artifacts. Next, the short-time
Fourier transformation (STFT) was used to capture the spec-
tral patterns in the EEG. Two EEG features were extracted
from the low delta band used to measure slow wave activity;
two features were extracted from the delta activity to describe
the K-complex; two features were extracted from the theta
activity tomeasure the theta background rhythm; two features
were extracted from the alpha activity to measure the alpha
background rhythm, and two features were extracted from the
sigma activity to represent the features of the spindle. Two
and one feature(s) are extracted from the beta and gamma
activities, respectively, to detect movement. Therefore, a total
of 13 features were extracted and used to construct the sleep
stage classification system.
The following were used to perform the classification:
the relevance vector machine (RVM), based on a Bayesian
framework, and a support vector machine (SVM) [45] that
learns the maximal probability of margins between binary
classes. Unlike the support vector machine, the RVM can
solve the overfitting problem, which typically occurs if SVM
requires too many support vectors, and the parameter setting
problem (i.e., penalty parameter/slack variable). Therefore,
in this sleep stage classification system, the RVM was used
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FIGURE 2. Sleep quality evaluation system. The input data are EEG signals
of Fp1 and Fp2, and then preprocessed by a down-sampled procedure
and a band-pass filter. Each of the processed data is transformed to a
13-dimensional feature vector used to construct the relevance vector
machine for the sleep stage classification (W, N1, N2, N3, and REM).
TABLE 1. Consistency Between the Sleep Stages scored by the Expert and
the Proposed System.
to classify the five sleep stages. Regarding the system perfor-
mance, the consistency between the clinical electrophysiolo-
gist and the proposed system was calculated. Additionally,
the Cohen’s kappa coefficient (κ) was estimated to mea-
sure the agreement between the specialist and the system.
When the specialist and the system were in complete agree-
ment, then κ = 1. When there was no agreement (other
than what would be expected by chance), then κ ≤ 0. The
performance of the proposed system was evaluated by the
leave-one-subject-out cross validation method.
C. CLASSIFICATION RESULTS
Fig. 3 presents a one-night sleep analysis based on the
developed classification system. In this case, the consis-
tency between the clinical electrophysiologist and the pro-
posed system was 79.9% and κ = 0.73. As displayed in
Table I, the classification accuracies of the W, N1, N2 N3,
and REM stages were 84.1%, 22.4%, 85.0%, 87.1%, and
83.2%, respectively. Most of the sleep stages, except for
FIGURE 3. Sleep analysis. (A) Sleep report of a night sleep estimated by
the proposed system. (B) Zoom-in view of spectral responses of Fp1
between 1:00-2:00 am. (C) Zoom-in view of the sleep report scored by the
proposed system. (D) Zoom-in view of the sleep report scored by the
clinical electrophysiologist.
the N1 stage, were effectively classified (>80%) using the
proposed system. Many epochs of N1 were misclassified as
W, N2, or REM. Identifying N1 was difficult [46] because
N1 is a transition phase between wakefulness and other sleep
stages. The sleep EEG characteristics of N1 closely resemble
those of N2, REM, and resting wakefulness. Efforts are under
way to solve this problem. The overall consistency between
the clinical electrophysiologist and the proposed system was
76.7%, and the overall Cohen’s kappa coefficient was κ =
0.689. The performance of the sleep stage classification sys-
tem with a forehead-only EEG is near that of a sleep expert.
IV. FOREHEAD EEG COMPLEXITY DYNAMICS BEFORE
MIGRAINE ATTACKS
Approximately 70-90% of migraine patients have migraines
without aura (MoA), meaning that there is no early warning
of imminent pain [47]. In the migraine cycle shown in Fig. 4,
the 72-hour period before a headache attack is defined as the
pre-ictal phase; the 72-hour period after a headache attack
is defined as the post-ictal phase; the period between the
pre- and post-ictal phases is the inter-ictal phase. It is impor-
tant to identify a biomarker that can differentiate between
the pre-ictal phase from the inter-ictal phase. Many stud-
ies [48], [49] have reported forehead cortex dysexcitability
in migraine patients. To model this abnormality, a multiscale
fuzzy entropy analysis (MFE) [50], [51] was performed on
the forehead EEG to compare the entropy values in the dif-
ferent phases of a migraine.
A. PATIENTS AND EXPERIMENT
A total of 40 MoA patients (10 men and 30 females, age
38.1±8.2 years) were recruited for this study. All patients
met the diagnostic criteria of the International Classification
of Headache Disorders (2nd edition) (ICHD-II) and suffered
from one to six attacks per month; the patients were required
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FIGURE 4. Migraine cycle. Four potential phases of migraines are pre-ictal
(the period of 72 hours before a headache attack), ictal (headache
attack), post-ictal (the period of 72 hours after a headache attack), and
inter-ictal (the period between the post-ictal phase and the pre-ictal
phase). To avoid the headache attack, predicting the EEG-based dynamic
complexity from the inter-ictal phase to the pre-ictal phase is desirable.
to keep a headache diary. The Institutional Review Board
of the Taipei Veterans General Hospital approved this study.
Informed consent was obtained from all subjects before test-
ing. The EEG recording from each migraine patient was
classified into one of the migraine phases (inter-ictal, pre-
ictal, ictal and post-ictal) based on the headache diaries.
This experiment was carried out in a lightless room in the
Taipei Veteran General Hospital. The fluorescent lamps were
turned off for the duration of the test to avoid interference
from a light source. Five EEG recordings were collected
for each patient every 3–15 days ; for each patient, at least
one test was conducted in the inter-ictal and pre-ictal phase,
separately. Eyes-closed resting EEG data were collected for
3 min from the Fpz site for each recording. Highly nonlinear
and non-stationary artifacts increase the standard deviation of
the data, which results in a poor estimation of brain complex-
ity; the empirical mode decomposition (EMD) method was
utilized as an adaptive filter to address this problem [52], [53],
and the detrended EEG data were then analyzed by MFE.
B. RESULTS
We compared the MFE areas in the inter-ictal and pre-ictal
phases. There was a significant difference between the inter-
ictal and pre-ictal phases (FDR-adjusted p-value<0.01) when
comparing the areas under the EMD-MFE curve from scale 1
to 20 (MFE Area1-20). The complexity values of the pre-ictal
phase significantly exceeded those of the inter-ictal phase
in 29 patients of 40 patients (72.5% of participants). The
patients who endured at least twice as many pre-ictal trials
were used to establish and quantify reproducibility. In our
study, eight migraine patients were selected and analyzed
by the test-retest reliability measurement. The result showed
that the intra-class correlation coefficient (ICC) was r=0.72
(p=0.02), supporting the reliability of elevated EEG com-
plexity occurring in the majority of migraine patients.
The hypo- or hyper normal brain activities may be driven
by impaired cognitive or pathological functions, leading to
dynamic changes of brain complexity and abnormal behav-
ioral patterns [54]. The dynamic changes of forehead EEG
complexity in migraines may be induced by the trigemi-
novascular pathway and sensitization of trigeminocervical
neurons [55]. Moreover, the forehead cortical areas were
found to modulate pain processing when a headache
occurs [56]. The unique EEG migraine pattern confirms that
monitoring the forehead EEG complexity in a resting state
is a promising means of warning a patient of an imminent
migraine hours in advance.
V. SCREENING DEPRESSION TREATMENT TO PREDICT
EFFICACY OF ANTIDEPRESSANT AGENTS
A. PATIENTS AND EXPERIMENT
A total of 20 participants (four men and 16 women, with
a mean age of 44.3±13.0 years) were recruited among the
outpatients of the Psychiatric Department of Taipei Veterans
General Hospital. All subjects met the criteria for treatment
resistant depression, and their initial scores were greater than
or equal to 15 on the 17-item Hamilton Rating Scale for
Depression (Ham-D-17) [57]. This study was approved by
the Institutional Review Board at the Taipei VGH hospital.
Informed consent was obtained from all subjects before they
participated in the study.
All participants received a ketamine (0.2∼0.5 mg/kg) infu-
sion. Each participant was requested to evaluate their depres-
sion a total of 13 times using Ham-D-17 scores. As shown in
Fig. 5, Ham-D-17 scores were recorded at 0 min (baseline),
40min (finished ketamine infusion), 80min, 2 hours, 4 hours,
24 hours (2 days), 48 hours (3 days), 72 hours (4 days),
96 hours (5 days), 6 days, 7 days, 14 days, and 28 days after
the treatment. All participants underwent neurophysiological
evaluations using a four-channel (AF7, Fp1, Fp2, AF8) dry-
contact EEG device with a 10 min closed-eyes recording at
baseline (0 min).
B. PREDICTION OF KETAMINE RESPONSE
The ultimate goal of this research is to predict the effi-
cacy of the ketamine treatment using baseline EEG activity
recorded before taking antidepressants. Based on the effects
of ketamine in depressed patients [58], depressive symptoms
may be significantly improve within four hours of a ketamine
infusion. Hence, a patient with a Ham-D-17 reduction of
at least 50% between 0 min and 4 hours was defined as a
responder; other patients were non-responders. In this study,
ten subjects (7 female and 3 male, age 39.5±12.1 years)
responded to treatment, and ten subjects (9 female and 1male,
age 49.0±12.6 years) did not respond to treatment.
The EEG theta activity has been suggested as a useful
biomarker inmajor depressive disorder for prediction of treat-
ment responses [26], [27]. To extract the treatment response
of theta activity, the 10 min EEG data—with a sampling rate
of 512 Hz—were transformed into the spectral power using
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FIGURE 5. (A) Ham-D-17 scores of 20 subjects from 0 min to 28 days. Patients with a Ham-D-17 reduction between 0 min and 4 hours of at least 50% are
defined as a responder (red traces); other patients are non-responders (blue traces). (B) Classification accuracies of distinct classifiers (LDA, NSMC, k-NN,
PARZEN, PERL, DRBM, and SVMRBF) in differentiating responders and non-responders.
fast Fourier transformation (FFT). The FFT window was set
to 0.5 s, comprised 256 data points, and overlapped 50%with
the next window. Each window of data was transformed into
the frequency domain and averaged based on the number of
segments, then the averaged FFT power was output. To elim-
inate the individual differences among power, the ratio of
absolute theta power (4–7 Hz) to total power (1–12 Hz) was
calculated. All relative theta powers of the four channels
and the corresponding labels of responder and non-responder
were used as themajor features to build the prediction system.
Seven well-known classifiers were implemented, includ-
ing linear discriminant analysis (LDA), k-nearest neighbors
(kNN, k=3), nearest mean classifier (NMSC), discrimina-
tive restricted Boltzmann machine (DRBMC), Parzen den-
sity estimation (PARZEN), perceptron classifier (PERLC),
and support vector machine with a radial basis function
(SVMRBF). A three-fold cross validation was performed
up to 100 times to evaluate the classification performance.
Finally, the accuracies of seven classifiers in predicting the
efficacy of the ketamine treatment were compared.
C. RESULTS
Fig. 5A presents the Ham-D-17 scores of 20 subjects from
0 min to 28 days. The red and blue lines represent the
Ham-D-17 scores of responders and non-responders, respec-
tively. The Ham-D-17 at the baseline was 20.9±5.4 for
responders and 22.9±4.3 for non-responders. After 4 hours,
the Ham-D-17 scores of responders and non-responders were
9.7±2.8 and 19.2±5.5, respectively. Regarding the frontal
EEG activity, the theta EEG powers of four frontal channels
(AF8, Fp2, Fp1, AF7) of the responders was significantly
lower than that of non-responders (FDR-adjusted p <0.05).
The EEG results suggest that frontal theta EEG power
(4–8 Hz power/1–12 Hz power) at pretreatment may be
used as a biomarker to differentiate responders from non-
responders.
The theta EEG powers of all channels were then used as
the featured input to train a two-class classifier (responder vs.
non-responder). Fig. 5B compares the classification accura-
cies of all trained classifiers. The RBF-based SVM classifier
reached the highest accuracy of 73.5±11.2% in classifying
EEG patterns of responders and non-responders, indicating
that the frontal theta EEG power at baseline may be useful
for predicting pretreatment responses.
VI. SUMMARY
The healthcare solutions presented in this paper are based on
the usefulness of the forehead EEGmeasured through a novel
wearable EEG device. The use of silicon-based electrodes
recording EEG from the forehead allows for easy and rapid
monitoring on an everyday basis. The cases presented in
this work are examples of the critical contribution of fore-
head EEG activity in various mental processes or patholo-
gies. In addition, we have demonstrated the feasibility of the
forehead EEG in support of healthcare needs such as sleep
monitoring, headache detection, and depression treatment.
Forehead EEG in neuroimaging can be used in other everyday
applications such as detecting the drowsiness during driv-
ing, designing brain-computer interfaces for disabled people,
controlling devices and environments, and incorporating a
real-time neurofeedback for enhancing cognitive functions.
However, decoding frontal activity may be problematic since
multiple mental processes activate the same area, which may
result in unwanted and unintended actions. Hence, spatial
resolution is a limitation of EEG-based systems, particularly
when the EEG-based healthcare system relies on an area
that is rich in subfunctions. The spatiotemporal distributions
of brain activity and network behavior provide significant
psychophysiological information. Therefore, it is important
to image brain functional connectivity to understand brain
function. There are ongoing advances in practical approaches
of brain signal recording and sophisticated designs of extract-
ing knowledge from neuro-information in the brain; home
healthcare solutions are envisioned to guide to a wide range
of real-life applications in the near future.
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